Sex differences in ischemic heart disease and heart failure biomarkers
Abstract Since 1984, each year, more women than men die of ischemic heart disease (IHD) and heart failure (HF), yet more men are diagnosed. Because biomarker assessment is often the first diagnostic employed in such patients, understanding biomarker differences in men vs. women may improve female mo...
Main Authors: | Kimia Sobhani, Diana K. Nieves Castro, Qin Fu, Roberta A. Gottlieb, Jennifer E. Van Eyk, C. Noel Bairey Merz |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-09-01
|
Series: | Biology of Sex Differences |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13293-018-0201-y |
Similar Items
-
Impact of Sex Differences and Diabetes on Coronary Atherosclerosis and Ischemic Heart Disease
by: Rosalinda Madonna, et al.
Published: (2019-01-01) -
Sex-based differences in remote monitoring of biometric, psychometric and biomarker indices in stable ischemic heart disease
by: Arnold, C., et al.
Published: (2022) -
Identification of sex‐specific biomarkers predicting new‐onset heart failure
by: Anne Raafs, et al.
Published: (2021-10-01) -
Diagnostic value of determination of galectin-3 - the new biomarker of the chronic heart failure
by: K. A Gyamdzhyan, et al.
Published: (2014-12-01) -
The Diagnostic and Therapeutic Value of Multimarker Analysis in Heart Failure. An Approach to Biomarker-Targeted Therapy
by: Albert Topf, et al.
Published: (2020-12-01)